Recent advances in pharmacological treatment of neuropathic pain

F1000 Medicine Reports

Volumn 2, Issue 1, 2010, Pages

  Finnerup, Nanna Brix ^a   Sindrup, Søren Hein ^b   Jensen, Troels Staehelin ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 AZETIDINYLMETHOXY) 2 CHLOROPYRIDINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BOTULINUM TOXIN A; CAPSAICIN; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; LIDOCAINE; OPIATE DERIVATIVE; OXCARBAZEPINE; PLACEBO; PREGABALIN; QUTENZA; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANTINOCICEPTION; ARTICLE; COMBINATION CHEMOTHERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; HUMAN; NERVE INJURY; NEUROPATHIC PAIN; UNSPECIFIED SIDE EFFECT;

EID: 77955074808     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M2-52     Document Type: Article

References (24)

1. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J: Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70:1630-5. (Pubitemid 351620320)
2. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH: Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005, 118:289-305. (Pubitemid 41752987)
3. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS: Pharmacologic management of neuropathic pain: Evidencebased recommendations. Pain 2007, 132:237-51.
4. Gordh TE, Stubhaug A, Jensen TS, Arner S, Biber B, Boivie J, Mannheimer C, Kalliomaki J, Kalso E: Gabapentin in traumatic nerve injury pain: A randomized, double-blind, placebocontrolled, cross-over, multi-center study. Pain 2008, 138: 255-66.
5. Stacey BR, Barrett JA, Whalen E, Phillips KF, Rowbotham MC: Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. J Pain 2008, 9:1006-17.
6. Vilholm OJ, Cold S, Rasmussen L, Sindrup SH: Effect of levetiracetam on the postmastectomy pain syndrome. Eur J Neurol 2008, 15:851-7.
7. Finnerup NB, Grydehoj J, Bing J, Johannesen IL, Biering-Sorensen F, Sindrup SH, Jensen TS: Levetiracetam in spinal cord injury pain: a randomized controlled trial. Spinal Cord 2009, 47:861-7.
8. Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, Gross HM, Renno SI, Nashawaty M, Loprinzi CL: Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 2008, 112:2802-8.
9. Wymer JP, Simpson J, Sen D, Bongardt S; Lacosamide SP742 Study Group: Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin J Pain 2009, 25:376-85.
10. Bansal D, Bhansali A, Hota D, Chakrabarti A, Dutta P: Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial. Diabet Med 2009, 26:1019-26.
11. Kajdasz DK, Iyengar S, Desaiah D, Backonja MM, Farrar JT, Fishbain DA, Jensen TS, Rowbotham MC, Sang CN, Ziegler D, McQuay HJ: Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, doubleblind, placebo-controlled, parallel-group studies. Clin Ther 2007, 29(Suppl):2536-46.
12. Otto M, Bach FW, Jensen TS, Brosen K, Sindrup SH: Escitalopram in painful polyneuropathy: A randomized, placebo-controlled, cross-over trial. Pain 2008, 139:275-83.
13. Wu CL, Agarwal S, Tella PK, Klick B, Clark MR, Haythornthwaite JA, Max MB, Raja SN: Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial. Anesthesiology 2008, 109:289-96.
14. Norrbrink C, Lundeberg T: Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebocontrolled trial. Clin J Pain 2009, 25:177-84.
15. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL: Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005, 352:1324-34.
16. Hanna M, O'Brien C, Wilson MC: Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008, 12:804-13.
17. Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL: Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009, 374:1252-61.
18. Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M: 5% lidocaine medicated plaster versus pregabalin in postherpetic neuralgia and diabetic polyneuropathy: an openlabel, non-inferiority two-stage RCT study. Curr Med Res Opin 2009, 25:1663-76.
19. Wong GY, Gavva NR: Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. Brain Res Rev 2009, 60:267-77.
20. Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan P, Jr., Rauck R, Tobias J: NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol 2008, 7:1106-12.
21. Simpson DM, Brown S, Tobias J: Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008, 70:2305-13.
22. Ranoux D, Attal N, Morain F, Bouhassira D: Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008, 64:274-83.
23. Yuan RY, Sheu JJ, Yu JM, Chen WT, Tseng IJ, Chang HH, Hu CJ: Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology 2009, 72:1473-8.
24. Rowbotham MC, Rachel DW, Thomas J, Nothaft W, Backonja MM: A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain. Pain 2009, 146:245-52.